Clinical Trial Update: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating the safety and preliminary efficacy of combining an anti-IGF-1R monoclonal antibody with an anti-PD-1 monoclonal antibody to tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Anti-IGF-1R monoclonal antibody
• Anti-PD-1 Monoclonal Antibody

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: mCRPC | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING